Skip to main content

Table 3 Comparisons of Behçet patients with different cardiovascular characteristics regarding disease activity score

From: The pattern of cardiovascular manifestations in Egyptian Behçet’s patients and its relation to disease activity

Cardiovascular parameters and lipid profile

BDCAF score

T test or ANOVA

N

Mean ± SD

T or F

p value

Lipid profile

Abnormal

24

7.500 ± 1.934

− 0.814

0.421

Normal

16

8.188 ± 3.410

Axis deviation

Negative

29

7.862 ± 2.850

0.339

0.736

Left

11

7.545 ± 1.916

Ventricular hypertrophy

Negative

28

7.643 ± 2.642

− 0.485

0.631

Left

12

8.083 ± 2.610

Bundle branch block

Negative

34

7.735 ± 2.678

0.367

0.695

Right

1

6.000 ± 0.000

Left

5

8.400 ± 2.408

Carotid duplex

Abnormal

3

7.667 ± 0.577

− 0.074

0.941

Normal

37

7.784 ± 2.709

Aortic valve

AR

4

9.500 ± 1.732

1.413

0.166

Normal

36

7.583 ± 2.634

Mitral valve

MR

7

10.286 ± 3.592

3.100

0.004*

Normal

33

7.242 ± 2.047

Tricuspid valve

TR

11

9.182 ± 3.125

2.204

0.034*

Normal

29

7.241 ± 2.214

Pulmonary valve

PR

5

7.000 ± 1.581

− 0.706

0.484

Normal

35

7.886 ± 2.720

Diastolic dysfunction

Positive

10

8.700 ± 3.302

1.308

0.199

Negative

30

7.467 ± 2.315

Intra cardiac masses

Positive

2

6.000 ± 1.414

− 0.988

0.330

Negative

38

7.868 ± 2.632

Vascular arterial affection (pulmonary)

Positive

3

8.667 ± 4.726

0.611

0.545

Negative

37

7.703 ± 2.459

Vascular venous affection

Positive

18

9.111 ± 2.610

3.279

0.002*

Negative

22

6.682 ± 2.079

  1. ANOVA analysis of variance, BDCAF Behçet’s Disease Current Activity Form, AR aortic regurgitation, MR mitral regurgitation, TR tricuspid regurgitation, PR pulmonary regurgitation, SD standard deviation
  2. *significant